Rhinomed Limited
(ASX:RNO) has announced it has received its Medical Device Establishment License from Health Canada for the distribution of its Turbine breathing and Mute sleep technology.
The regulatory license enables Rhinomed to import and sell both products into Canada and continue dialogue with the distributors seeking to distribute the Mute and Turbine in the region.
The company will seek to distribute the Turbine through the Canadian cycling, triathlon and sporting store outlets and major retailers.
Distribution of the mute product is planned to be through pharmacies.
Rhinomed reported a loss of $5.31 million at 30 June 2015.
